デフォルト表紙
市場調査レポート
商品コード
1599233

静脈穿刺手技市場:静脈タイプ別、エンドユーザー別-2025-2030年の世界予測

Venipuncture Procedure Market by Vein Type (Basilic Vein, Cephalic Vein, Median Cubital Vein), End-User (Diagnostic Laboratories, Hospital, Physician Offices/Clinics) - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 199 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
静脈穿刺手技市場:静脈タイプ別、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

静脈穿刺手技市場は、2023年に12億2,000万米ドルと評価され、2024年には12億9,000万米ドルに達すると予測され、CAGR 6.00%で成長し、2030年には18億4,000万米ドルになると予測されています。

静脈からの採血を伴う一般的な医療処置である静脈穿刺は、診断検査、献血、治療管理に不可欠です。静脈穿刺の必要性は、日常的な健康診断、病状のモニタリング、血液サンプルを必要とする臨床検査で生じる。その用途は病院、診断ラボ、血液銀行、クリニックにまたがり、ヘルスケアシステムの重要な部分を形成しています。最終用途の範囲には主に医療提供者や検査技師が含まれ、患者の診断や治療管理を容易にします。市場の洞察によると、人口の高齢化、慢性疾患の増加、予防ヘルスケア重視の高まりなどの要因が静脈穿刺処置の需要を促進しています。さらに、静脈の可視化や針を使わない方法など、先進的な静脈穿刺装置や技術の導入は、特に医療インフラが成熟した地域に潜在的な成長機会をもたらしています。しかし、市場の限界としては、地域によるヘルスケア慣行の違い、手技合併症のリスク、高度な手技に伴う高コストなどがあり、これが普及の妨げになる可能性があります。課題として挙げられるのは、静脈穿刺を正確かつ効率的に行う熟練した専門家の不足です。この分野におけるイノベーションは、施術者の熟練度を高めるための、使いやすく費用対効果の高いツールやトレーニングプログラムの開発に重点を置くことができます。自動化、AI統合、エラー率低減のための安全機能向上は、研究開発の有望分野です。静脈穿刺市場は、技術の進歩と競争圧力によって特徴付けられ、各社は機器の効率と患者の快適性の向上に注力しています。市場の性質はダイナミックであり、技術革新と進化するヘルスケア・ニーズに後押しされています。企業にとっては、医療機関との戦略的パートナーシップや、革新的で侵襲の少ない代替医療を開発するための研究開発への投資が、新たな動向を活用し、現在の市場の課題に効果的に対処するために推奨されます。

主な市場の統計
基準年[2023] 12億2,000万米ドル
予測年[2024] 12億9,000万米ドル
予測年[2030] 18億4,000万米ドル
CAGR(%) 6.00%

市場力学:急速に進化する静脈穿刺手技市場の主要市場インサイトを公開

静脈穿刺手技市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 慢性疾患の世界の有病率の上昇
    • 製薬・バイオ医薬品業界による研究開発能力への注目の高まり
    • 高齢者人口の増加とヘルスケア・インフラ整備のための支出増
  • 市場抑制要因
    • 新興経済諸国および低開発経済諸国における標準化の欠如
  • 市場機会
    • 検査・診断機器の技術進歩
    • 静脈穿刺手技の継続的進歩
  • 市場の課題
    • 新興諸国における不利な償還政策と熟練医療従事者の不足

ポーターの5つの力:静脈穿刺手技市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:静脈穿刺手技市場における外部からの影響の把握

外部マクロ環境要因は、静脈穿刺手技市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析静脈穿刺手技市場における競合情勢の把握

静脈穿刺手技市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス静脈穿刺手技市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、静脈穿刺手技市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨静脈穿刺手技市場における成功への道筋を描く

静脈穿刺手技市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の有病率が世界的に上昇
      • 製薬業界およびバイオ医薬品業界による研究開発能力への重点化
      • 高齢化人口の増加とヘルスケアインフラ整備への支出増加
    • 抑制要因
      • 発展途上国および後進国における標準化の欠如
    • 機会
      • 検査・診断機器の技術的進歩
      • 静脈穿刺手順の継続的な進歩
    • 課題
      • 新興諸国における不利な償還政策と熟練した医療専門家の不足
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 静脈穿刺手技市場静脈の種類別

  • バジル静脈
  • 橈側静脈
  • 正中肘静脈

第7章 静脈穿刺手技市場:エンドユーザー別

  • 診断検査室
  • 病院
  • 医師のオフィス/クリニック

第8章 南北アメリカの静脈穿刺手技市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の静脈穿刺手技市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの静脈穿刺手技市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Abbott Laboratories
  • AccuVein Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • bioMerieux S.A.
  • Cardinal Health, Inc.
  • Christie Medical Holdings, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Henry Schein, Inc.
  • Hindustan Syringes & Medical Devices Ltd.
  • ICU Medical Inc.
  • Kyoto Kagaku Co., Ltd.
  • LUMITOS AG
  • Medline Industries, Inc.
  • Merck KGaA
  • P. H. Healthcare Pvt. Ltd.
  • Parker Hannifin Corporation
  • Sharn Inc.
  • Thermo Fisher Scientific Inc.
  • TransLite LLC
  • Venoscope, LLC
図表

LIST OF FIGURES

  • FIGURE 1. VENIPUNCTURE PROCEDURE MARKET RESEARCH PROCESS
  • FIGURE 2. VENIPUNCTURE PROCEDURE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. VENIPUNCTURE PROCEDURE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. VENIPUNCTURE PROCEDURE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VENIPUNCTURE PROCEDURE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VENIPUNCTURE PROCEDURE MARKET DYNAMICS
  • TABLE 7. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY BASILIC VEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CEPHALIC VEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY MEDIAN CUBITAL VEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PHYSICIAN OFFICES/CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM VENIPUNCTURE PROCEDURE MARKET SIZE, BY VEIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM VENIPUNCTURE PROCEDURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. VENIPUNCTURE PROCEDURE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. VENIPUNCTURE PROCEDURE MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-FF012EDC38B4

The Venipuncture Procedure Market was valued at USD 1.22 billion in 2023, expected to reach USD 1.29 billion in 2024, and is projected to grow at a CAGR of 6.00%, to USD 1.84 billion by 2030.

Venipuncture, a common medical procedure involving the collection of blood from a vein, is essential for diagnostic testing, blood donation, and administering treatments. The necessity of venipuncture arises in routine health check-ups, monitoring medical conditions, and clinical tests requiring blood samples. Its application spans across hospitals, diagnostic labs, blood banks, and clinics, forming a significant part of the healthcare system. The end-use scope predominantly includes healthcare providers and laboratory technicians, facilitating patient diagnosis and treatment management. Market insights reveal that factors such as an aging population, rise in chronic diseases, and increased emphasis on preventive healthcare are driving demand for venipuncture procedures. Moreover, the introduction of advanced venipuncture devices and techniques, such as vein visualization and needle-free methods, offers potential growth opportunities, especially in regions with a mature healthcare infrastructure. However, market limitations include variations in healthcare practices across regions, risk of procedural complications, and high costs associated with advanced techniques, which may impede adoption. An identified challenging factor is the shortage of skilled professionals to perform venipuncture accurately and efficiently. Innovation in this space can focus on developing user-friendly, cost-effective tools and training programs to enhance practitioner proficiency. Automation, AI integration, and improved safety features for reduced error rates are promising areas for research and development. The venipuncture market is characterized by technological advancements and competitive pressures, with companies focusing on improving device efficiency and patient comfort. The nature of the market is dynamic, driven by technological innovation and evolving healthcare needs. For businesses, strategic partnerships with healthcare institutions and investment in R&D to develop innovative, less invasive alternatives are recommended to capitalize on emerging trends and address current market challenges effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 1.22 billion
Estimated Year [2024] USD 1.29 billion
Forecast Year [2030] USD 1.84 billion
CAGR (%) 6.00%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Venipuncture Procedure Market

The Venipuncture Procedure Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic disorders globally
    • Increased focus on R&D proficiencies by the pharmaceutical and biopharmaceutical industries
    • Growing geriatric population and rising expenditure for the development of healthcare infrastructure
  • Market Restraints
    • Lack of standardization in the developing and underdeveloped economies
  • Market Opportunities
    • Technological advancements in the testing and diagnosing instruments
    • Ongoing advancements in venipuncture procedures
  • Market Challenges
    • Unfavorable reimbursement policies and lack of skilled medical professionals in developing countries

Porter's Five Forces: A Strategic Tool for Navigating the Venipuncture Procedure Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Venipuncture Procedure Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Venipuncture Procedure Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Venipuncture Procedure Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Venipuncture Procedure Market

A detailed market share analysis in the Venipuncture Procedure Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Venipuncture Procedure Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Venipuncture Procedure Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Venipuncture Procedure Market

A strategic analysis of the Venipuncture Procedure Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Venipuncture Procedure Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuVein Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, bioMerieux S.A., Cardinal Health, Inc., Christie Medical Holdings, Inc., Fresenius Medical Care AG & Co. KGaA, Henry Schein, Inc., Hindustan Syringes & Medical Devices Ltd., ICU Medical Inc., Kyoto Kagaku Co., Ltd., LUMITOS AG, Medline Industries, Inc., Merck KGaA, P. H. Healthcare Pvt. Ltd., Parker Hannifin Corporation, Sharn Inc., Thermo Fisher Scientific Inc., TransLite LLC, and Venoscope, LLC.

Market Segmentation & Coverage

This research report categorizes the Venipuncture Procedure Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Vein Type, market is studied across Basilic Vein, Cephalic Vein, and Median Cubital Vein.
  • Based on End-User, market is studied across Diagnostic Laboratories, Hospital, and Physician Offices/Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic disorders globally
      • 5.1.1.2. Increased focus on R&D proficiencies by the pharmaceutical and biopharmaceutical industries
      • 5.1.1.3. Growing geriatric population and rising expenditure for the development of healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of standardization in the developing and underdeveloped economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the testing and diagnosing instruments
      • 5.1.3.2. Ongoing advancements in venipuncture procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Unfavorable reimbursement policies and lack of skilled medical professionals in developing countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Venipuncture Procedure Market, by Vein Type

  • 6.1. Introduction
  • 6.2. Basilic Vein
  • 6.3. Cephalic Vein
  • 6.4. Median Cubital Vein

7. Venipuncture Procedure Market, by End-User

  • 7.1. Introduction
  • 7.2. Diagnostic Laboratories
  • 7.3. Hospital
  • 7.4. Physician Offices/Clinics

8. Americas Venipuncture Procedure Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Venipuncture Procedure Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Venipuncture Procedure Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AccuVein Inc.
  • 3. B. Braun Melsungen AG
  • 4. Becton, Dickinson and Company
  • 5. bioMerieux S.A.
  • 6. Cardinal Health, Inc.
  • 7. Christie Medical Holdings, Inc.
  • 8. Fresenius Medical Care AG & Co. KGaA
  • 9. Henry Schein, Inc.
  • 10. Hindustan Syringes & Medical Devices Ltd.
  • 11. ICU Medical Inc.
  • 12. Kyoto Kagaku Co., Ltd.
  • 13. LUMITOS AG
  • 14. Medline Industries, Inc.
  • 15. Merck KGaA
  • 16. P. H. Healthcare Pvt. Ltd.
  • 17. Parker Hannifin Corporation
  • 18. Sharn Inc.
  • 19. Thermo Fisher Scientific Inc.
  • 20. TransLite LLC
  • 21. Venoscope, LLC